4 Analysts Assess Haemonetics: What You Need To Know
4 Analysts Assess Haemonetics: What You Need To Know
4 位分析师评估血液学：你需要知道的
During the last three months, 4 analysts shared their evaluations of Haemonetics (NYSE:HAE), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，4位分析师分享了他们对Haemonetics（纽约证券交易所代码：HAE）的评估，揭示了从看涨到看跌的不同前景。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表简要概述了分析师最近的评级，提供了对过去30天情绪变化的见解，并与前几个月进行了比较以获得整体视角。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $110.5, a high estimate of $125.00, and a low estimate of $105.00. Witnessing a positive shift, the current average has risen by 2.0% from the previous average price target of $108.33.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为110.5美元，最高估计为125.00美元，低估值为105.00美元。当前的平均价格从之前的平均目标价108.33美元上涨了2.0％，出现了积极的变化。
Decoding Analyst Ratings: A Detailed...
解码分析师...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。